Filter By Category
Archives
Share on -
ALDESLEUKIN
Generic Name: ALDESLEUKIN
ABSTRACT -
Aldesleukin activates lymphocytes through IL-2 receptors and has been used in specialist oncology settings. High-dose administration requires intensive monitoring because of capillary-leak and organ-toxicity risks.
DOSAGE -
Use the current locally approved prescribing information where a product is authorized. For investigational products, dose, route, schedule, premedication, and dose modifications must come only from the applicable clinical-trial protocol. No dose should be selected from this summary.
SIDE EFFECTS–
- Fever and chills
- Low blood pressure
- Fluid retention and capillary leak
- Kidney or liver dysfunction
- Confusion or fatigue
- Cardiac or respiratory complications
ALLRGIC REACTIONS–
(These symptoms may indicate a serious allergic or infusion reaction and require medical attention.)
- Hives or a rapidly spreading rash
- Swelling of the face, lips, tongue, or throat
- Wheezing, breathing difficulty, or sudden dizziness
- Severe blistering, mucosal lesions, or anaphylaxis
DRUG INTERACTIONS–
- Other nephrotoxic, cardiotoxic, or hypotensive agents may increase toxicity
- Corticosteroids can antagonize immune activation in some settings
PREAUTIONS–
- Administer only in experienced specialist centres
- Monitor haemodynamics, oxygenation, kidney, liver, and neurologic status
WARNINGS –
- Capillary-leak syndrome and multi-organ toxicity can be fatal
- Stop treatment promptly for severe organ dysfunction
Share on -
. Developed by